Latest News & Analysis
markets
Market Index Performance | August 2026
Our monthly update detailing the short- and long-term performance of major indices.
stocks
Ahead of an IPO, the maths behind Databrick’s $190 billion valuation doesn’t add up
The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.
stocks
Takeover proposal agreed for ASX share, other offers permitted
Morningstar analysts’ take on the takeover for this undervalued industrial player.
stocks
Our top ASX picks in every sector
These companies are our favourite choices for investors wanting to boost Aussie equity exposure.
stocks
Berkshire Hathaway: Warren Buffett takes another step back; Howard Buffett elected Chairman
We don’t expect much to change as Warren Buffett moves into his new role as chairman emeritus.
markets
How Australia compares with 9 other countries at turning savers into investors
Australia delivers an effective investment ecosystem despite comparatively weaker disclosure and portfolio-transparency standards.
stocks
AI stocks stumble amid growing safety fears
Warnings from Anthropic, OpenAI, and SpaceX are raising questions over the future of the AI buildout.
personal-finance
Unconventional wisdom: Why investing gets harder as you get older
Three tips to navigate the shifting wealth building playbook for older investors.
personal-finance
How wealthy are you compared to other Aussies?
Mark and Shani run through the numbers that define the wealthiest Australians.
markets
Will AI destroy investor capital?
Are collapsing costs and drained moats impacting the companies you own?
stocks
Chart of the Week: BHP’s valuation hits historic levels
BHP and peers are trading as if the copper boom is here to stay.
stocks
3 cheap wide moat growth stocks
4 and 5 star companies that can protect and grow their earnings.
personal-finance
Do you qualify as ‘rich’?
The ambiguous and wide ranging definitions of what it is to be rich shows the importance of setting goals.
stocks
ASX biotech expands diagnostics portfolio after FDA approval
FDA nod adds another growth driver for ASX share.
stocks
Is it time to bail on Australian stocks?
Is your home bias costing your portfolio better returns?
of 697
Viewing 1 to 16 of 11147